| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. | President and CFO | Common Stock | 369,004 | $27,730,650 | $75.15 | 12 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | 12 Dec 2025 | 1 | -$1,039,024 | 4 | President and CFO | 16 Dec 2025, 18:25 |
| BBIO | BridgeBio Pharma, Inc. | 16 Nov 2025 | 3 | -$2,540,640 | 4 | President and CFO | 18 Nov 2025, 19:28 |
| BBIO | BridgeBio Pharma, Inc. | 21 Aug 2025 | 1 | -$2,090,081 | 4 | President and CFO | 22 Aug 2025, 16:58 |
| BBIO | BridgeBio Pharma, Inc. | 16 Aug 2025 | 3 | -$1,965,711 | 4 | President and CFO | 19 Aug 2025, 19:40 |
| BBIO | BridgeBio Pharma, Inc. | 16 May 2025 | 1 | -$721,367 | 4 | President and CFO | 20 May 2025, 17:07 |
| BBIO | BridgeBio Pharma, Inc. | 19 Mar 2025 | 1 | $0 | 4 | President and CFO | 21 Mar 2025, 18:32 |
| BBIO | BridgeBio Pharma, Inc. | 16 Feb 2025 | 1 | -$480,992 | 4 | President and COO | 19 Feb 2025, 20:51 |
| BBIO | BridgeBio Pharma, Inc. | 10 Dec 2024 | 1 | $0 | 4 | President and COO | 12 Dec 2024, 19:00 |
| BBIO | BridgeBio Pharma, Inc. | 16 Nov 2024 | 1 | -$425,442 | 4 | President and COO | 19 Nov 2024, 18:13 |
| BBIO | BridgeBio Pharma, Inc. | 16 Aug 2024 | 1 | -$437,638 | 4 | President and COO | 20 Aug 2024, 18:24 |
| BBIO | BridgeBio Pharma, Inc. | 06 Aug 2024 | 2 | $0 | 4 | President and COO | 08 Aug 2024, 16:39 |
| BBIO | BridgeBio Pharma, Inc. | 23 Jul 2024 | 0 | $0 | 3 | President and COO | 29 Jul 2024, 20:16 |